BNP Paribas Financial Markets’s VolitionRx Ltd VNRX Stock Holding History
Bought
Maintained
Sold
Other funds holding VNRX
VCM
WANY
VFT
SBCM
TRCT
AAP
BNP Paribas Financial Markets's VNRX Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its VolitionRx Ltd (VNRX) stake by 7.7% in Q2 2026, buying an estimated $2 and bringing the position to 14 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #5853.
BNP Paribas Financial Markets first reported a position in VNRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $17.8K in Q3 2020. 19 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.
- BNP Paribas Financial Markets held 14 shares of VolitionRx Ltd worth $19 as of Q2 2026.
- BNP Paribas Financial Markets bought 1 VolitionRx Ltd share in Q2 2026, an estimated $2.
- VolitionRx Ltd made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5853 holding.
- BNP Paribas Financial Markets first reported a position in VolitionRx Ltd in Q2 2020 and has held it in 25 quarters since.
- BNP Paribas Financial Markets's VolitionRx Ltd position peaked at $17.8K in Q3 2020.
- 19 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.